Watch Ticker

Eton Pharmaceutcials, Inc. Common Stock

Go to Eton Pharmaceutcials, Inc. Common Stock Website

$15.00

0.27 (1.83%)

Live

Previous Close

$14.73

Day Range

$0 - $0

Previous Day Range

$13.985 - $14.755

Market Cap

$385.9 million USD

Day Vol.

Previous Day Vol.

268629

Currency

USD

Primary Exchange

Nasdaq

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkin...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Eton Pharmaceuticals - Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET

Related tickers: ETON.

Read Full Article

Eton Pharmaceuticals - Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that Sean Brynjelsen, Chief Executive Officer, and James Gruber, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference in New York as follows:

Related tickers: ETON.

Read Full Article

Trending Tickers

Please sign in to view